BREAKWATER: 2026 Update: Dr. Kopetz (2026)

BOT+BAL trial for MSS CRC: Dr. DeVito (2025)

Targeting KRAS for Patients with CRC: Dr. Sahin (2025)

Understanding Your Biomarker Report: Dr. Strickler (2025)

BRAF Poster: Dr Maddelena (2025)

KRAS G12C trial: Dr. Parseghian (2024)

Early-stage BRAF V600E MSS colon cancer — What’s next after adjuvant treatment: Dr. Yaeger (2024)

NEST-1 trial: Dr. Kasi (2024)

Treatment strategies for early-stage MSI-H colon cancer: Dr. Sharif (2023)

BREAKWATER trial: Dr. Kopetz (2023)

Targeting RAS mutations in CRC: Dr. Lenz (2022)

BRAF-mutated CRC updates: Dr. Corcoran (2022)

CtDNA DYNAMIC II clinical trial: Dr. Tie (2022)

Defining early-onset CRC and improving outcomes for MSI-H rectal cancer: Dr. Cercek (2022)

HER2 as an emerging target for metastatic CRC patients: Dr. Strickler (2022)

CtDNA testing for patients undergoing liver resection: Dr. Newhook (2022)

CAMILLA trial — Cabo + Durva for metastatic refractory MSS CRC: Dr. Saeed (2022)

CtDNA screening tests and the CIRCULATE-US trial: Dr. Lieu (2022)

KRAS therapies for CRC: Dr. Kopetz (2022)

HERKULES-3 trial for BRAF and RAS: Dr. Lee (2021)

Defining early-onset CRC and improving outcomes for MSI-H rectal cancer: Dr. Cercek (2022)

Immunotherapy in MSS Colorectal Cancer: Dr. Fakih (2022)

Circulating tumor DNA: a new frontier in colorectal cancer: Dr. Cohen (2021)

Tackling targeted therapy refractory BRAF V600E mCRC: Dr. Kopetz (2021)

Targeted therapies and immunotherapy: Dr. Morris (2020)

Overview of BRAF treatment options: Dr. Kopetz (2020)

BRAF V600E research update: Dr. Corcoran (2020)

New treatment strategies for MSS CRC: Dr. Parikh (2021)

The TIL trial for metastatic CRC: Drs. Lou and Starr (2021)